 |
PDBsum entry 1ak5
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Oxidoreductase
|
PDB id
|
|
|
|
1ak5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Biochemistry
36:10666-10674
(1997)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of Tritrichomonas foetus inosine-5'-monophosphate dehydrogenase and the enzyme-product complex.
|
|
F.G.Whitby,
H.Luecke,
P.Kuhn,
J.R.Somoza,
J.A.Huete-Perez,
J.D.Phillips,
C.P.Hill,
R.J.Fletterick,
C.C.Wang.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Inosine-5'-monophosphate dehydrogenase (IMPDH) is an attractive drug target for
the control of parasitic infections. The enzyme catalyzes the oxidation of
inosine monophosphate (IMP) to xanthosine monophosphate (XMP), the committed
step in de novo guanosine monophosphate (GMP) biosynthesis. We have determined
the crystal structures of IMPDH from the protozoan parasite Tritrichomonas
foetus in the apo form at 2.3 A resolution and the enzyme-XMP complex at 2.6 A
resolution. Each monomer of this tetrameric enzyme is comprised of two domains,
the largest of which includes an eight-stranded parallel beta/alpha-barrel that
contains the enzyme active site at the C termini of the barrel beta-strands. A
second domain, comprised of residues 102-220, is disordered in the crystal.
IMPDH is expected to be active as a tetramer, since the active site cavity is
formed by strands from adjacent subunits. An intrasubunit disulfide bond, seen
in the crystal structure, may stabilize the protein in a less active form, as
high concentrations of reducing agent have been shown to increase enzyme
activity. Disorder at the active site suggests that a high degree of flexibility
may be inherent in the catalytic function of IMPDH. Unlike IMPDH from other
species, the T. foetus enzyme has a single arginine that is largely responsible
for coordinating the substrate phosphate in the active site. This structural
uniqueness may facilitate structure-based identification and design of compounds
that specifically inhibit the parasite enzyme.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
D.R.Gollapalli,
I.S.Macpherson,
G.Liechti,
S.K.Gorla,
J.B.Goldberg,
and
L.Hedstrom
(2010).
Structural determinants of inhibitor selectivity in prokaryotic IMP dehydrogenases.
|
| |
Chem Biol,
17,
1084-1091.
|
 |
|
|
|
|
 |
L.Hedstrom
(2009).
IMP dehydrogenase: structure, mechanism, and inhibition.
|
| |
Chem Rev,
109,
2903-2928.
|
 |
|
|
|
|
 |
J.Y.Ha,
J.Y.Min,
S.K.Lee,
H.S.Kim,
d.o. .J.Kim,
K.H.Kim,
H.H.Lee,
H.K.Kim,
H.J.Yoon,
and
S.W.Suh
(2006).
Crystal structure of 2-nitropropane dioxygenase complexed with FMN and substrate. Identification of the catalytic base.
|
| |
J Biol Chem,
281,
18660-18667.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
N.N.Umejiego,
C.Li,
T.Riera,
L.Hedstrom,
and
B.Striepen
(2004).
Cryptosporidium parvum IMP dehydrogenase: identification of functional, structural, and dynamic properties that can be exploited for drug design.
|
| |
J Biol Chem,
279,
40320-40327.
|
 |
|
|
|
|
 |
R.Laupitz,
S.Hecht,
S.Amslinger,
F.Zepeck,
J.Kaiser,
G.Richter,
N.Schramek,
S.Steinbacher,
R.Huber,
D.Arigoni,
A.Bacher,
W.Eisenreich,
and
F.Rohdich
(2004).
Biochemical characterization of Bacillus subtilis type II isopentenyl diphosphate isomerase, and phylogenetic distribution of isoprenoid biosynthesis pathways.
|
| |
Eur J Biochem,
271,
2658-2669.
|
 |
|
|
|
|
 |
B.Striepen,
M.W.White,
C.Li,
M.N.Guerini,
S.B.Malik,
J.M.Logsdon,
C.Liu,
and
M.S.Abrahamsen
(2002).
Genetic complementation in apicomplexan parasites.
|
| |
Proc Natl Acad Sci U S A,
99,
6304-6309.
|
 |
|
|
|
|
 |
G.L.Prosise,
J.Z.Wu,
and
H.Luecke
(2002).
Crystal structure of Tritrichomonas foetus inosine monophosphate dehydrogenase in complex with the inhibitor ribavirin monophosphate reveals a catalysis-dependent ion-binding site.
|
| |
J Biol Chem,
277,
50654-50659.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
S.J.Bowne,
L.S.Sullivan,
S.H.Blanton,
C.L.Cepko,
S.Blackshaw,
D.G.Birch,
D.Hughbanks-Wheaton,
J.R.Heckenlively,
and
S.P.Daiger
(2002).
Mutations in the inosine monophosphate dehydrogenase 1 gene (IMPDH1) cause the RP10 form of autosomal dominant retinitis pigmentosa.
|
| |
Hum Mol Genet,
11,
559-568.
|
 |
|
|
|
|
 |
C.Breithaupt,
J.Strassner,
U.Breitinger,
R.Huber,
P.Macheroux,
A.Schaller,
and
T.Clausen
(2001).
X-ray structure of 12-oxophytodienoate reductase 1 provides structural insight into substrate binding and specificity within the family of OYE.
|
| |
Structure,
9,
419-429.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
B.M.Goldstein,
and
T.D.Colby
(2000).
Conformational constraints in NAD analogs: implications for dehydrogenase binding and specificity.
|
| |
Adv Enzyme Regul,
40,
405-426.
|
 |
|
|
|
|
 |
F.M.McMillan,
M.Cahoon,
A.White,
L.Hedstrom,
G.A.Petsko,
and
D.Ringe
(2000).
Crystal structure at 2.4 A resolution of Borrelia burgdorferi inosine 5'-monophosphate dehydrogenase: evidence of a substrate-induced hinged-lid motion by loop 6.
|
| |
Biochemistry,
39,
4533-4542.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.A.Digits,
and
L.Hedstrom
(2000).
Drug selectivity is determined by coupling across the NAD+ site of IMP dehydrogenase.
|
| |
Biochemistry,
39,
1771-1777.
|
 |
|
|
|
|
 |
K.M.Kerr,
J.A.Digits,
N.Kuperwasser,
and
L.Hedstrom
(2000).
Asp338 controls hydride transfer in Escherichia coli IMP dehydrogenase.
|
| |
Biochemistry,
39,
9804-9810.
|
 |
|
|
|
|
 |
M.D.Sintchak,
and
E.Nimmesgern
(2000).
The structure of inosine 5'-monophosphate dehydrogenase and the design of novel inhibitors.
|
| |
Immunopharmacology,
47,
163-184.
|
 |
|
|
|
|
 |
G.D.Markham,
C.L.Bock,
and
C.Schalk-Hihi
(1999).
Acid-base catalysis in the chemical mechanism of inosine monophosphate dehydrogenase.
|
| |
Biochemistry,
38,
4433-4440.
|
 |
|
|
|
|
 |
J.A.Digits,
and
L.Hedstrom
(1999).
Kinetic mechanism of Tritrichomonas foetus inosine 5'-monophosphate dehydrogenase.
|
| |
Biochemistry,
38,
2295-2306.
|
 |
|
|
|
|
 |
J.A.Digits,
and
L.Hedstrom
(1999).
Species-specific inhibition of inosine 5'-monophosphate dehydrogenase by mycophenolic acid.
|
| |
Biochemistry,
38,
15388-15397.
|
 |
|
|
|
|
 |
K.Pawłowski,
B.Zhang,
L.Rychlewski,
and
A.Godzik
(1999).
The Helicobacter pylori genome: from sequence analysis to structural and functional predictions.
|
| |
Proteins,
36,
20-30.
|
 |
|
|
|
|
 |
R.Zhang,
G.Evans,
F.J.Rotella,
E.M.Westbrook,
D.Beno,
E.Huberman,
A.Joachimiak,
and
F.R.Collart
(1999).
Characteristics and crystal structure of bacterial inosine-5'-monophosphate dehydrogenase.
|
| |
Biochemistry,
38,
4691-4700.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
T.D.Colby,
K.Vanderveen,
M.D.Strickler,
G.D.Markham,
and
B.M.Goldstein
(1999).
Crystal structure of human type II inosine monophosphate dehydrogenase: implications for ligand binding and drug design.
|
| |
Proc Natl Acad Sci U S A,
96,
3531-3536.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.Schalk-Hihi,
Y.Z.Zhang,
and
G.D.Markham
(1998).
The conformation of NADH bound to inosine 5'-monophosphate dehydrogenase determined by transferred nuclear Overhauser effect spectroscopy.
|
| |
Biochemistry,
37,
7608-7616.
|
 |
|
|
|
|
 |
K.M.Kerr,
and
L.Hedstrom
(1997).
The roles of conserved carboxylate residues in IMP dehydrogenase and identification of a transition state analog.
|
| |
Biochemistry,
36,
13365-13373.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |